Blood-brain barrier dysfunction in brain diseases: clinical experience.
about
Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound.Quantitative imaging assessment of blood-brain barrier permeability in humans.miR-21 improves the neurological outcome after traumatic brain injury in rats.Stress-dose hydrocortisone reduces critical illness-related corticosteroid insufficiency associated with severe traumatic brain injury in rats.Blood cells and endothelial barrier function.Overview and introduction: the blood-brain barrier in health and diseaseImaging blood-brain barrier dysfunction in animal disease models.Inflammatory cytokine network in schizophrenia.Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic?The Protective Effects of Sufentanil Pretreatment on Rat Brains under the State of Cardiopulmonary Bypass.Matrix metalloproteinases and epileptogenesis.Microvasculature of the Mouse Cerebral Cortex Exhibits Increased Accumulation and Synthesis of Hyaluronan With Aging.PKA activation and endothelial claudin-5 breakdown in the schizophrenic prefrontal cortex.Micro(glial)-managing executive function: white matter inflammation drives catatonia.Intravascular Inflammation Triggers Intracerebral Activated Microglia and Contributes to Secondary Brain Injury After Experimental Subarachnoid Hemorrhage (eSAH).Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction.Long-term consequences of single and multiple mild blast exposure on select physiological parameters and blood-based biomarkers.The Role of Cannabis within an Emerging Perspective on Schizophrenia
P2860
Q30370894-EB97D756-634B-488F-AC7E-9443C4AADE13Q30587216-204B092E-B0DE-4EF8-ADE9-EF4F5806D168Q30596128-3A342FB2-60C7-4910-8F38-86DA285E7E88Q33754846-68A1A5F4-823B-42A0-9627-E6C1D916B670Q35212839-85D5B709-9759-4AEE-9995-C7E5BE293438Q38058369-7354266E-56E3-4997-88F4-298A1F8BFDF5Q38058371-518DFE58-D00D-43C8-8DC6-781399FDBFEAQ38138169-29209F65-A85E-47E6-9109-8170F196BEC3Q38164039-F53646B2-D2E6-403D-B3D8-F7F0B988477FQ39786024-4487CC45-0E41-48AA-9CE4-CB3E5FBEA3AEQ42078040-127BC687-3B96-4B76-AB4E-816C61254969Q45058665-F739A092-D785-4E00-882D-A108AAB844D9Q47123064-F4D59EE9-ACCC-4B84-ACCB-A9D96F09B0B4Q47281589-1D34DA89-ECFE-48E0-8D14-D5BD09FC842AQ47403429-6884DBC9-7058-4763-912B-63A87A679C97Q47940187-D0B6FB84-908D-4FA9-9949-50B2737013FFQ50956180-89894ADB-4CC1-4CF4-A842-D7B88C16E9B2Q58794814-E794F0F2-CFC5-4FAF-9757-E6EA111B25E9
P2860
Blood-brain barrier dysfunction in brain diseases: clinical experience.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Blood-brain barrier dysfunction in brain diseases: clinical experience.
@en
type
label
Blood-brain barrier dysfunction in brain diseases: clinical experience.
@en
prefLabel
Blood-brain barrier dysfunction in brain diseases: clinical experience.
@en
P2860
P1433
P1476
Blood-brain barrier dysfunction in brain diseases: clinical experience.
@en
P2093
Hadar Shalev
Karl Schoknecht
P2860
P356
10.1111/J.1528-1167.2012.03697.X
P478
53 Suppl 6
P577
2012-11-01T00:00:00Z